EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSATEG00000016378
Gene Symbol: DHCR24
3 Cross references
209 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 11a

Ensembl ID : ENSATEG00000011929
Gene Symbol: LOC113153514
2 Cross references
198 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 4-Like

Ensembl ID : ENSATEG00000023903
Gene Symbol: LOC113168830
3 Cross references
221 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase

Ensembl ID : ENSATEG00000008992
Gene Symbol: LOC113151273
2 Cross references
194 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase-Like

Ensembl ID : ENSATEG00000007723
Gene Symbol: LOC113159262
2 Cross references
206 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1b

Ensembl ID : ENSATEG00000015476
Gene Symbol: PDPK1B
3 Cross references
222 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase B

Ensembl ID : ENSATEG00000021342
Gene Symbol: HPDB
2 Cross references
207 Possible Orthologues:

40s Ribosomal Protein S19

Ensembl ID : ENSATEG00000010310
Gene Symbol: LOC113154668
2 Cross references
288 Possible Orthologues:

40s Ribosomal Protein S26

Ensembl ID : ENSATEG00000001893
Gene Symbol: LOC113153399
2 Cross references
416 Possible Orthologues:

5'-Nucleotidase Ecto

Ensembl ID : ENSATEG00000002145
Gene Symbol: NT5E
1 Cross references
190 Possible Orthologues:

5'-Nucleotidase Ecto

Ensembl ID : ENSATEG00000014109
Gene Symbol: NT5E
1 Cross references
194 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 1b

Ensembl ID : ENSATEG00000014131
Gene Symbol: HTR1B
2 Cross references
183 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).